EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieBeobachtungsstudieOpen Access

Early Outcomes Between the Two Latest Generation Mitral Valve Transcatheter Edge‐to‐Edge Repair Devices: OCEAN‐Mitral Registry

Yusuke Enta iD, Masanori Yamamoto iD, Hirofumi Hioki iD, Shunsuke Kubo iD, Mike Saji iD, Masahiko Asami iD, Shinichi Shirai iD, Masaki Izumo, Shingo Mizuno, Yusuke Watanabe, Yuki Izumi, Makoto Amaki iD und 12 weitere

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70702 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Yusuke Enta und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve, Cardiac Catheterization, Heart Valve Prosthesis Implantation. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Edwards Lifesciences, Abbott Medical Japan, Boston Scientific Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The PASCAL (PASCAL Precision, Edwards Lifesciences) device for mitral valve transcatheter edge‐to‐edge repair (M‐TEER) was recently introduced in Japan for treating primary mitral regurgitation (PMR). This multicenter study aimed to compare the clinical outcomes of the latest‐generation M‐TEER systems: PASCAL and MitraClip (Generation 4, Abbott Vascular).

Methods

Data from 150 consecutive patients with significant PMR who underwent M‐TEER with the PASCAL were extracted from the Japanese OCEAN‐Mitral registry. The early procedural safety and clinical outcomes of PASCAL were compared with those of a historical cohort of 679 patients treated with MitraClip for PMR. Propensity score (PS)‐matching analysis was performed to minimize differences in baseline characteristics.

Results

Among the PASCAL cohort, one case of 30‐day non‐cardiac mortality occurred, with no deployment failures or need for additional surgery. A single leaflet device attachment (SLDA) case occurred after releasing one of the two PASCAL lockline sutures; however, successful retrieval of the device resulted in no final SLDA cases. After PS‐matching, the rates of MR grade ≤ 2+ were comparable between the groups at 30‐day (92.3% vs. 92.1%, p = 0.89). Similarly, rates of MR ≤ 1+ showed no significant differences at 30‐day (71.6% vs. 65.8%, p = 0.18). Both the device and clinical success rates were similar between the groups (95.0% vs. 92.1%, p = 0.33; 93.5% vs. 87.8%, p = 0.10, respectively).

Conclusions

This study revealed no significant differences in the early clinical outcomes after M‐TEER between the latest‐generation devices. The PASCAL system, with its distinctive structure, may be associated with a low incidence of SLDA and may represent a potential alternative option for the treatment of PMR. Clinical trials: OCEAN‐Mitral registry (UMIN‐ID: UMIN000023653).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyMitral ValveCardiac CatheterizationHeart Valve Prosthesis ImplantationHeart Valve ProsthesisHumansRegistriesFemaleTime FactorsTreatment OutcomeMaleAgedJapanProsthesis DesignRisk FactorsAged, 80 and overRecovery of FunctionRetrospective StudiesHemodynamics

Stichwörter der Autor:innen

MitraClip G4PASCAL precisionmitral regurgitationmitral valve transcatheter edge‐to‐edge repairprimary mitral regurgitation

Autor:innen und Institutionen

  • Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
  • Department of Cardiology, Toyohashi Heart Center, Toyohashi, Japan.
  • Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
  • Department of Cardiology, Gifu Heart Center, Gifu, Japan.
  • Department of Cardiology, IMS Tokyo Katsushika General Hospital, Tokyo, Japan.
  • Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.

ORCID-Profile: Yusuke Enta, Masanori Yamamoto, Hirofumi Hioki, Shunsuke Kubo, Mike Saji, Masahiko Asami, Shinichi Shirai, Makoto Amaki, Hisao Otsuki, Daisuke Hachinohe, Toru Naganuma, Yohei Ohno, Hiroshi Ueno, Gaku Nakazawa, Toshiaki Otsuka, Kentaro Hayashida

Förderung

  • Edwards Lifesciences
  • Abbott Medical Japan
  • Boston Scientific Japan
  • Medtronic Japan
  • Daiichi-Sankyo

Zitieren

APA

Enta, Y., Yamamoto, M., Hioki, H., Kubo, S., Saji, M., Asami, M., Shirai, S., Izumo, M., Mizuno, S., Watanabe, Y., Izumi, Y., Amaki, M., Kodama, K., Otsuki, H., Hachinohe, D., Naganuma, T., Bota, H., Ohno, Y., Okazaki, S., …, & OCEAN‐Mitral investigators (2026). Early Outcomes Between the Two Latest Generation Mitral Valve Transcatheter Edge‐to‐Edge Repair Devices: OCEAN‐Mitral Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70702

Vancouver

Enta Y, Yamamoto M, Hioki H, Kubo S, Saji M, Asami M, et al. Early Outcomes Between the Two Latest Generation Mitral Valve Transcatheter Edge‐to‐Edge Repair Devices: OCEAN‐Mitral Registry. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70702

BibTeX
@article{Enta2026,
  author = {Enta, Yusuke and Yamamoto, Masanori and Hioki, Hirofumi and Kubo, Shunsuke and Saji, Mike and Asami, Masahiko and Shirai, Shinichi and Izumo, Masaki and Mizuno, Shingo and Watanabe, Yusuke and Izumi, Yuki and Amaki, Makoto and Kodama, Kazuhisa and Otsuki, Hisao and Hachinohe, Daisuke and Naganuma, Toru and Bota, Hiroki and Ohno, Yohei and Okazaki, Shinya and Ueno, Hiroshi and Nakazawa, Gaku and Otsuka, Toshiaki and Hayashida, Kentaro and OCEAN‐Mitral investigators, OCEAN‐Mitral investigators},
  title = {Early Outcomes Between the Two Latest Generation Mitral Valve Transcatheter Edge‐to‐Edge Repair Devices: OCEAN‐Mitral Registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70702}
}
Kostenlos starten →